Patent Assignment
Reel/Frame 067663/0365
Assignment of Assignor's Interest
Recorded: 2024-06-06
Pages: 23
Assignors
ROSSI, LUIGIA
Executed: 2024-01-11
MAMBRINI, GIOVANNI
Executed: 2024-01-09
ALIANO, MATTIA PAOLO
Executed: 2024-01-11
BIANCHI, MARZIA
Executed: 2024-01-11
PIERIGE, FRANCESCA
Executed: 2024-01-11
MAGNANI, MAURO
Executed: 2024-01-11
Assignee
ERYDEL S.P.A.
VIA A. MEUCCI, 3, BRESSO, 20091, ITALY
Covered Property
(1)
Engineering New Metabolic Pathways in Isolated Cells for the Degradation of Guanidinoacetic Acid and Simultaneous Production of Creatine
Application:
18/563,750 →
Publication:
US 2025/0340852
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jun 6, 2024
From: ERYDEL S.P.A.
To: QUINCE THERAPEUTICS S.P.A.
Reel/Frame 067663/0413 →
Assignment of Assignor's Interest
Jan 5, 2026
From: QUINCE THERAPEUTICS S.P.A.
To: QUINCE THERAPEUTICS, INC.
Reel/Frame 074201/0923 →
Assignment of Assignor's Interest
Jun 17, 2026
From: QUINCE THERAPEUTICS, INC.
To: AYMA THERAPEUTICS INC.
Reel/Frame 075892/0192 →